Boston Startup Reels in $44 Million; In Process of Hiring and Leasing Lab Space

Anew Cambridge biotech will be working on a treatment using stem cells that could let children and adults with Type 1 diabetes do something their bodies currently cannot: produce their own insulin, the hormone that keeps blood sugar levels in balance. Semma Therapeutics is already off to a strong start.

http://ift.tt/1Fzuks3